查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1820340

2025 年至 2033 年弹性体输液帮浦市场规模、份额、趋势及预测（按产品、应用、最终用户和地区）

Elastomer Infusion Pump Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球弹性体输液帮浦市场规模为 12.3 亿美元。预计到 2033 年，该市场将达到 23.2 亿美元，2025 年至 2033 年的复合年增长率为 7.3%。北美目前占据市场主导地位，2024 年的市占率将超过 41.7%。市场驱动力来自日益增强的以病人为中心的照护需求、家庭治疗和精准的药物传递系统。疼痛治疗、术后护理和慢性病治疗的应用不断扩大，以及技术进步和对治疗效率和安全性的重视，也正在推动其应用。便携式、易于使用和一次性输液泵正成为医院、诊所和家庭护理的必需品。所有这些因素共同促进了弹性体输液帮浦市场占有率的成长。

全球范围内对高效可持续医疗保健解决方案的日益重视，正成为推动医疗设备和药物输送系统改进的重要驱动力。全球各地的政府和医疗保健系统正更加重视旨在提高病患安全、降低交叉污染风险并最大限度提高治疗效率的创新。医疗保健提供者越来越认识到正确用药和最大限度减少错误的重要性，这促使人们采用精准输液设备。消息人士称，2025年4月，贝朗公司（B. Braun）在美国推出了Spaceplus和弹性输液泵系统，增强了弹性输液泵市场，提高了输液的准确性、安全性和临床有效性。此外，以患者为中心的护理模式（例如家庭治疗和门诊服务）的新兴趋势，正在推动对便携式、用户友好型、能够控制和持续输送药物的设备的需求。对提高治疗效果和降低资源利用率的关注有助于满足全球医疗保健优先事项，刺激对尖端输液解决方案的投资。法规、专业兴趣和以患者为中心的护理的融合正在推动全球市场的强劲增长，并决定着全球医疗器材采用的进程。

在美国，受个人化照护和以患者为中心的治疗方案需求成长的推动，弹性体输液帮浦市场在2024年将占据87.50%的市场份额，并将持续强劲成长。医疗保健专业人员越来越重视个人化治疗方案，而这需要精准一致的药物传递技术。对病人安全性、便利性和舒适性的日益关注，进一步推动了便携式和易用输液设备在临床和家庭护理中的应用。此外，美国医疗保健体係正在向门诊治疗和家庭疗法转型，以减少住院率、最大限度地利用资源并提高患者满意度。医疗技术的突破、护理模式的转变以及对治疗精准度日益增长的期望，都在巩固弹性体输液系统的普及。美国将以患者为中心的护理与临床有效性相结合，仍然是高端输液设备的重要成长区域，预计其市场需求将稳定成长。

弹性体输液帮浦市场趋势：

癌症发生率上升推动化疗市场

癌症发生率的上昇在很大程度上推动了化疗的需求，这主要源于缺乏运动、环境污染以及全球范围内的烟草和酒精消费。光是在美国，2025年就将新增2,041,910例癌症确诊病例和618,120例死亡病例，显示对有效治疗方案的需求迫切。在全球范围内，城市化、生活方式和环境因素也是癌症发病率上升的原因，因此化疗已成为医护人员的优先事项。先进的药物输送系统，尤其是弹性输液泵，对于确保治疗的精准性、安全性和患者舒适度至关重要。它们能够实现间歇性和连续性药物输送，消除给药错误，并提高治疗的一致性。在弹性输液帮浦市场趋势的背景下，安全、可靠且以患者为中心的输液解决方案的普及率日益增长，这表明这些技术对肿瘤治疗的重要性日益凸显，尤其是在门诊和居家治疗环境中，便利性和准确性至关重要。

老年人口扩大治疗需求

全球老年人口成长迅速，预计2070年代末，65岁以上老年人口将达22亿，超过18岁以下人口总数。老化也会使细胞修復效率丧失，导致癌症风险加倍，进而导致慢性病发生率上升。因此，老年患者越来越需要频繁的化疗和支持性治疗。一次性单次输注弹性帮浦在预防交叉污染风险和提供安全、精准的药物治疗方面尤其有效，尤其适用于居家护理治疗。以病人为中心和微创治疗方法的需求日益增长，进一步凸显了先进输注系统的重要性。顺应市场趋势，老年人口的成长以及对安全、有效和患者友善治疗的日益重视，正在推动美国弹性体输注帮浦市场的持续成长。先进的输注设备正成为满足老年治疗需求不可或缺的一部分，在当代医疗保健服务中兼具便利性和精准性。

居家护理和术后疼痛管理

外科治疗（尤其是骨科和术后治疗）的成长推动了对有效疼痛管理系统的需求。弹性输液帮浦可确保止痛药的可控单次输注，从而消除剂量错误以及对病人和医护人员的交叉污染风险。医院也越来越多地推行家庭护理，以减少住院时间、提高患者舒适度并更好地处理患者数量。便携式、轻巧且用户友好的弹性输液泵正在取代门诊和住院环境中的传统电动输液系统。门诊和家庭治疗的趋势，以及对安全性、便利性和治疗效果的日益关注，正在推动这些系统的普及。顺应市场趋势，医疗保健提供者正在寻求一致、符合患者依从性且精准的给药解决方案。这一趋势在美国弹性输液帮浦应用的发展中发挥重要作用，尤其是在术后治疗和家庭治疗计画中。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球弹性体输液帮浦市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 连续速率泵
  • 变数泵

第七章：市场区隔：依应用

  • 疼痛管理
  • 感染管理
  • 化疗
  • 其他的

第 8 章：市场区隔：依最终用户

  • 医院和诊所
  • 门诊护理
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Avanos Medical Inc.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Daiken Medical Co. Ltd.
    • Nipro Corporation
    • O&M Halyard Inc
    • Palex Medical SA
    • Pfizer Inc. (Hospira Inc.)
    • pfm medical ag.
    • Samtronic Industria e Comercio LTDA
    • Smiths Group plc.
    • Woo Young Medical Co. Ltd
Product Code: SR112025A4289

The global elastomer infusion pump market size was valued at USD 1.23 Billion in 2024. The market is projected to reach USD 2.32 Billion by 2033, exhibiting a CAGR of 7.3% from 2025-2033. North America currently dominates the market, holding a market share of over 41.7% in 2024. The market is fueled by intensified patient-focused care demand, home therapy, and accurate drug delivery systems. Expanding use in pain treatment, post-surgery care, and treatment of chronic diseases, along with technology advancements and emphasis on treatment efficiency and safety, are also driving adoption. Portable, easy-to-use, and disposable infusion pumps are becoming a necessity in hospitals, clinics, and home care. All of these factors together are adding to the growth of the elastomer infusion pump market share.

The growing worldwide emphasis on efficient and sustainable healthcare solutions is serving as an important driving force behind the implementation of improved medical devices and drug delivery systems. Governments and healthcare systems globally, across regions, are placing greater focus on innovations that improve patient safety, reduce the chance of cross-contamination risks, and maximize treatment efficiency. There is increasing recognition among healthcare providers for the significance of proper administration of medications and minimizing errors, which is inducing adoption of precision-based infusion devices. According to the sources, in April 2025, B. Braun's introduction of the Spaceplus and elastomeric infusion pump systems to the U.S. reinforced the elastomer infusion pump market, improving accuracy, safety, and clinical effectiveness. Moreover, the emerging trend toward patient-centric care models, such as home therapy and outpatient services, is driving demand for portable and user-friendly devices that are capable of controlled and consistent drug delivery. The focus on enhancing treatment effectiveness and decreasing resource utilization helps meet global healthcare priorities, stimulating investment in cutting-edge infusion solutions. This confluence of regulation, professional interest, and patient-oriented care is propelling strong market growth globally and determining the course of worldwide medical device adoption.

In the United States, the market for elastomer infusion pumps with 87.50% share in 2024 is growing robustly, fueled by boosting demand for personalized care and patient-centered treatment protocols. Healthcare professionals are placing more and more importance on customized treatment regimens that require accurate and consistent drug delivery technology. The increasing attention to patient safety, convenience, and comfort has further spurred the use of portable and easy-to-use infusion devices both in clinical settings and home care. Furthermore, the United States healthcare is transitioning towards outpatient treatments and home therapies as means to decrease hospitalizations, maximize the utilization of resources, and improve patient satisfaction. Medical technology breakthroughs, changing models of care, and increasing expectations for the accuracy of treatment are all solidifying the incorporation of elastomeric infusion systems. Combining patient-centered care and clinical effectiveness, the United States remains a growth area of prime importance for sophisticated infusion devices, with uptake forecast to grow steadily.

Elastomer Infusion Pump Market Trends:

Rising Incidence of Cancer Driving Chemotherapy Market

Increasing incidence of cancer is largely propelling the demand for chemotherapy, driven by physical inactivity, environmental pollution, and worldwide consumption of tobacco and alcohol. In the United States alone, 2025 will witness 2,041,910 new cancer diagnoses and 618,120 fatalities, indicating the pressing need for effective therapeutic options. Worldwide, urbanization, lifestyle, and environmental factors are also responsible for increasing cancer rates, thus creating a priority for chemotherapy among healthcare professionals. Sophisticated drug delivery systems, especially elastomeric infusion pumps, are indispensable to guarantee treatment precision, safety, and patient comfort. They enable intermittent and continuous drug delivery, eliminating errors in dosing and enhancing therapy consistency. In the context of elastomer infusion pump market trends, growing up-take of safe, reliable, and patient-centric infusion solutions is apparent, indicative of the greater significance of these technologies to oncology treatment, particularly in outpatient and home-based treatment environments where convenience and accuracy are of greatest concern.

Geriatric Population Amplifying Treatment Needs

The world geriatric population is growing fast, with those over 65 years set to reach 2.2 billion in the late 2070s, outnumbering the population of persons under 18 years. Aging also doubles cancer risk when cellular repair efficiency is lost, leading to amplified rates of chronic disease. As such, elderly patients increasingly need frequent chemotherapy and supportive therapy. Single-infusion elastomeric pumps that are disposable are especially useful in preventing cross-contamination risks and delivering safe, precise drug therapy, particularly for home-care therapy. The accelerating demand for patient-focused and minimally invasive treatment methods further underscores the importance of advanced infusion systems. In line with market trends, the confluence of a growing elderly population and greater emphasis on safe, effective, and patient-friendly therapies is propelling consistent elastomer infusion pump market growth in the U.S. Sophisticated infusion equipment is becoming integral to handling geriatric treatment needs, providing both convenience and treatment accuracy in contemporary healthcare service delivery.

Home-Based Care and Post-Operative Pain Management

The growth in surgical treatments, especially orthopedic and post-operative treatments, is driving demand for effective pain management systems. Elastomeric infusion pumps ensure controlled single-infusion administration of analgesics, eliminating dosing errors and cross-contamination hazards to patients and healthcare personnel. Hospitals are also pushing home care more and more to decrease inpatient stays, enhance patient comfort, and better handle mounted patient volumes. Portable, light, and user-friendly elastomeric pumps are replacing conventional electric infusion systems in outpatient as well as inpatient environments. The trend towards outpatient and home-oriented therapy, along with increasing focus on safety, convenience, and treatment efficacy, is supporting adoption of these systems. In accordance with trends in the market, healthcare providers are seeking consistent, patient-compliant, and accurate drug-delivery solutions. This trend is playing an important role in the development of elastomeric infusion pump use in the U.S., especially for post-operative treatment and home therapy programs.

Elastomer Infusion Pump Industry Segmentation:

Analysis by Product:

  • Continuous Rate Pumps
  • Variable Rate Pumps

Continuous rate pumps are a prominent segment in the elastomer infusion pump market outlook with a share of 59.2% in 2024, as they are capable of delivering drugs with high precision and uniformity over a prolonged duration. The pumps are commonly used in clinical environments as they provide controlled drug delivery and minimize the risk of dosing errors, which helps in enhancing patient outcomes. Their ability to deliver continuous infusion without the need for repeated adjustments makes them ideal for critical therapies, such as chemotherapy, antibiotics, and pain relief. Continuous rate pumps are also very compatible with hospital and home-care settings, with portability and convenience for patients needing treatment over long periods or as outpatients. Further, improvements in elastomer technology have increased reliability and safety in these pumps, reducing contamination risks and ease of operation. The emphasis on patient-driven care, in addition to the demand for efficient and easy medication administration, is fueling growth and acceptance of continuous rate pumps through worldwide healthcare systems.

Analysis by Application:

  • Pain Management
  • Infection Management
  • Chemotherapy
  • Others

Pain management is one of the most important uses propelling the elastomer infusion pump market with a market share of share of 39.8% in 2024. The equipment provides accurate, controlled analgesic delivery, delivering effective post-operative and chronic pain management with decreased dependence on oral drugs. Elastomer infusion pumps are especially valuable in post-surgical care, allowing healthcare professionals to control pain effectively and customize treatment for unique patient requirements. Their portability enables patients to continue therapy in home-care or outpatient locations, enhancing comfort and compliance. Single-use, disposable designs further minimize infection risks, which is especially important in pain management situations that frequently involve extended infusion. With hospitals and clinics increasingly focusing on patient-centered strategies and improved recovery protocols, elastomer infusion pumps have become a critical component of successful pain control therapies. The heightened emphasis on quality improvement, shorter hospital stays, and fewer complications highlights the role of pain management as the primary growth driver for this segment.

Analysis by End User:

  • Hospitals and Clinics
  • Ambulatory Care
  • Others

According to elastomer infusion pump market analysis, in 2024 with a share of 47.6%, hospitals and clinics are a prevalent end-user segment of the market because these institutions have a great need for efficient and effective drug delivery systems. Hospitals and clinics provide various types of therapies, such as chemotherapy, antibiotics, and pain control, that necessitate continuous and accurate infusion. Elastomer pumps have numerous benefits in healthcare settings, such as ease of portability, simplicity of use, and lower cross-contamination risks due to their disposable nature. Furthermore, they aid outpatient and home-care programs, consistent with contemporary patient-focused treatment models and hospital efficiency goals. The growing volume of surgical procedures and chronic disease management also stimulates demand for infusion solutions within hospitals and clinics. With healthcare facilities concentrating on enhancing the quality of treatment, reducing errors, and maximizing workflow efficiency, elastomer infusion pumps became a critical tool. Their broad acceptance guarantees precise, safe, and easy therapy administration in all clinical settings, making this segment a key market driver.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America is a key region in the elastomer infusion pump market with a share of share of 41.7% in 2024, boosting from advanced healthcare infrastructure, heightening patient awareness, and use of advanced drug delivery systems. The concentration of the region on patient-focused care, home-based therapy, and outpatient care has enhanced demand for user-friendly, portable infusion devices. Clinics and hospitals in North America increasingly opt for elastomer pumps due to their reliability, safety, and potential for lowering cross-contamination, especially in post-operative care and pain management. Regulatory endorsement, technological innovations, and strong healthcare spending also underpin broad usage throughout the U.S. and Canada. North America is also reinforced by an expanding elderly population that demands more long-term therapies demanding precise infusion solutions. Ongoing efforts to drive treatment efficiency, patient safety, and comfort place the region at the forefront of a critical market for elastomer infusion pumps. The convergence of innovation, infrastructure, and shifting care models guarantees consistent growth and leadership of North America in this market.

Key Regional Takeaways:

United States Elastomer Infusion Pump Market Analysis

United States is witnessing increasing elastomer infusion pump adoption due to shifting preferences towards home-based care. For instance, every year, approximately 12 Million Americans receive home health care services. As patients seek convenient and cost-effective treatment options, home-based care is becoming a favorable alternative to hospital stays, especially for post-operative and chronic pain management. This shift is driving demand for portable, user-friendly medical devices like elastomer infusion pumps, which offer continuous drug delivery without the need for electronic components. Advancements in outpatient care models and an aging population preferring in-home recovery are further boosting adoption. Healthcare providers are also encouraging early discharge strategies that support self-administration therapies, enhancing the demand for such infusion solutions.

Asia Pacific Elastomer Infusion Pump Market Analysis

Asia-Pacific is experiencing increased elastomer infusion pump usage due to the rising number of orthopedic procedures and surgeries. For instance, the India orthopedic devices market size was valued at USD 2.62 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 4.53 Billion by 2033, exhibiting a CAGR of 5.80% from 2025-2033. The surge in musculoskeletal conditions, road injuries, and sports-related trauma has led to higher orthopedic interventions, demanding effective pain management tools. Elastomer infusion pumps, offering reliable, continuous drug delivery, are becoming vital in post-surgical recovery. Growing investment in healthcare infrastructure and the expansion of surgical facilities across this region are further strengthening the market. Healthcare professionals are favoring these devices for their portability and ease of use in outpatient settings.

Europe Elastomer Infusion Pump Market Analysis

Europe is registering growing adoption of elastomer infusion pumps owing to the rising geriatric population. According to WHO, the population aged 60 and older is rapidly growing in the WHO European Region. In 2021, there were 215 Million; by 2030, it is projected to be 247 Million, and by 2050, over 300 Million. The elderly demographic is more susceptible to chronic diseases, surgeries, and long-term pain, necessitating reliable infusion solutions. Elastomer infusion pumps, known for their simplicity and reduced risk of complications, are ideal for home and hospital-based elderly care. Healthcare systems are focusing on aging-related care models that support non-invasive, continuous drug delivery solutions. With an emphasis on improving quality of life for older patients, demand for user-friendly infusion options is increasing.

Latin America Elastomer Infusion Pump Market Analysis

Latin America shows rising elastomer infusion pump adoption due to boosting cancer cases. For instance, in Brazil, the National Cancer Institute (INCA) estimates that, for each year of the 2023-2025 triennium, 704 thousand new cancer cases have occurred. The growing oncology burden demands efficient and continuous drug delivery for pain management and chemotherapy. Elastomer infusion pumps provide a non-electric, portable option for delivering analgesics and anti-cancer drugs. With limited healthcare access in some areas, these pumps support outpatient and home-based cancer care, enhancing patient comfort.

Middle East and Africa Elastomer Infusion Pump Market Analysis

Middle East and Africa is witnessing increasing elastomer infusion pump adoption due to growing healthcare facilities. For instance, in 2025, the UAE is currently home to over 150 hospitals and has more than 5,000 healthcare facilities. As medical infrastructure expands, demand for effective post-surgical and chronic pain management tools is increasing. Elastomer infusion pumps offer cost-effective, easy-to-use solutions for hospitals and outpatient centers. Healthcare investments and the development of specialized care units are further driving the usage of these devices for patient-controlled infusion therapy.

Competitive Landscape:

The market competition of elastomer infusion pumps is defined by ongoing innovation, technological developments, and strategic action to improve product performance and availability. Major players are working on developing portable, user-friendly, and disposable infusion systems in order to address the growing need for patient-centered care, home therapy, and outpatient services. Market outlook suggests continued growth led by intensifying adoption of elastomeric infusion solutions by hospitals, clinics, and home-care facilities. Focusing on enhancing accuracy of treatment, reducing cross-contamination, and increasing patient comfort is driving product development initiatives and prompting larger market penetration. Cooperation among healthcare professionals, technology developers, and regulatory agencies is also supporting developments in pump design, material safety, and infusion efficiency. With the elastomer infusion pump market forecast anticipating steady growth in the years to come, innovation, reliability, and flexibility are becoming the main drivers shaping the competitive landscape, allowing businesses to take advantage of established and rising healthcare markets.

The report provides a comprehensive analysis of the competitive landscape in the elastomer infusion pump market with detailed profiles of all major companies, including:

  • Avanos Medical Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Daiken Medical Co. Ltd.
  • Nipro Corporation
  • O&M Halyard Inc
  • Palex Medical S.A.
  • Pfizer Inc. (Hospira Inc.)
  • pfm medical ag.
  • Samtronic Industria e Comercio LTDA
  • Smiths Group plc.
  • Woo Young Medical Co. Ltd.

Key Questions Answered in This Report

  • 1.How big is the elastomer infusion pump market?
  • 2.What is the future outlook of elastomer infusion pump market?
  • 3.What are the key factors driving the elastomer infusion pump market?
  • 4.Which region accounts for the largest elastomer infusion pump market share?
  • 5.Which are the leading companies in the global elastomer infusion pump market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Elastomer Infusion Pump Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Continuous Rate Pumps
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Variable Rate Pumps
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Pain Management
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Infection Management
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Chemotherapy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Care
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Avanos Medical Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Baxter International Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Daiken Medical Co. Ltd.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Nipro Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 O&M Halyard Inc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Palex Medical S.A.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Pfizer Inc. (Hospira Inc.)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 pfm medical ag.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Samtronic Industria e Comercio LTDA
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Smiths Group plc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Woo Young Medical Co. Ltd
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Elastomer Infusion Pump Market: Major Drivers and Challenges
  • Figure 2: Global: Elastomer Infusion Pump Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Elastomer Infusion Pump Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Elastomer Infusion Pump Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Elastomer Infusion Pump Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Elastomer Infusion Pump Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Elastomer Infusion Pump Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Elastomer Infusion Pump (Continuous Rate Pumps) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Elastomer Infusion Pump (Continuous Rate Pumps) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Elastomer Infusion Pump (Variable Rate Pumps) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Elastomer Infusion Pump (Variable Rate Pumps) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Elastomer Infusion Pump (Pain Management) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Elastomer Infusion Pump (Pain Management) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Elastomer Infusion Pump (Infection Management) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Elastomer Infusion Pump (Infection Management) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Elastomer Infusion Pump (Chemotherapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Elastomer Infusion Pump (Chemotherapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Elastomer Infusion Pump (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Elastomer Infusion Pump (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Elastomer Infusion Pump (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Elastomer Infusion Pump (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Elastomer Infusion Pump (Ambulatory Care) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Elastomer Infusion Pump (Ambulatory Care) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Elastomer Infusion Pump (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Elastomer Infusion Pump (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Elastomer Infusion Pump Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Elastomer Infusion Pump Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Elastomer Infusion Pump Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Elastomer Infusion Pump Industry: SWOT Analysis
  • Figure 76: Global: Elastomer Infusion Pump Industry: Value Chain Analysis
  • Figure 77: Global: Elastomer Infusion Pump Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Elastomer Infusion Pump Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Elastomer Infusion Pump Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Elastomer Infusion Pump Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Elastomer Infusion Pump Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Elastomer Infusion Pump Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Elastomer Infusion Pump Market: Competitive Structure
  • Table 7: Global: Elastomer Infusion Pump Market: Key Players